Neuroscience: Optical control of reward.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 19396134)

Published in Nature on April 23, 2009

Authors

David E Moorman, Gary Aston-Jones

Articles by these authors

A role for lateral hypothalamic orexin neurons in reward seeking. Nature (2005) 5.41

Decision making, the P3, and the locus coeruleus-norepinephrine system. Psychol Bull (2005) 3.97

Arousal and reward: a dichotomy in orexin function. Trends Neurosci (2006) 2.79

Linking context with reward: a functional circuit from hippocampal CA3 to ventral tegmental area. Science (2011) 2.48

Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology (2008) 2.06

Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons. J Neurosci (2002) 2.00

Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction. Brain Res (2009) 1.79

Lateral hypothalamic orexin neurons are critically involved in learning to associate an environment with morphine reward. Behav Brain Res (2007) 1.73

Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking. Eur J Neurosci (2009) 1.67

Critical role for ventral tegmental glutamate in preference for a cocaine-conditioned environment. Neuropsychopharmacology (2003) 1.60

Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct Funct (2008) 1.54

Phasic activation of monkey locus ceruleus neurons by simple decisions in a forced-choice task. J Neurosci (2004) 1.51

Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity. Physiol Behav (2010) 1.50

Testing equality of several functions: analysis of single-unit firing-rate curves across multiple experimental conditions. Stat Med (2007) 1.34

Orexin/hypocretin is necessary for context-driven cocaine-seeking. Neuropharmacology (2009) 1.29

Altered motivation and learning following opiate withdrawal: evidence for prolonged dysregulation of reward processing. Neuropsychopharmacology (2003) 1.26

Multiple roles for orexin/hypocretin in addiction. Prog Brain Res (2012) 1.26

Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS). Neuropsychopharmacology (2010) 1.25

Selective loss of catecholaminergic wake active neurons in a murine sleep apnea model. J Neurosci (2007) 1.21

Enhanced morphine preference following prolonged abstinence: association with increased Fos expression in the extended amygdala. Neuropsychopharmacology (2003) 1.19

Posttraining optogenetic manipulations of basolateral amygdala activity modulate consolidation of inhibitory avoidance memory in rats. Proc Natl Acad Sci U S A (2013) 1.16

Adrenergic and noradrenergic innervation of the midbrain ventral tegmental area and retrorubral field: prominent inputs from medullary homeostatic centers. J Neurosci (2009) 1.15

Role of the bed nucleus of the stria terminalis in the control of ventral tegmental area dopamine neurons. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.15

α(2) Adrenergic and imidazoline receptor agonists prevent cue-induced cocaine seeking. Biol Psychiatry (2011) 1.15

Activation of monkey locus coeruleus neurons varies with difficulty and performance in a target detection task. J Neurophysiol (2004) 1.15

Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) (2012) 1.15

Designer receptor manipulations reveal a role of the locus coeruleus noradrenergic system in isoflurane general anesthesia. Proc Natl Acad Sci U S A (2014) 1.13

Orexin-1 receptor antagonism decreases ethanol consumption and preference selectively in high-ethanol--preferring Sprague--Dawley rats. Alcohol (2009) 1.13

Activation in extended amygdala corresponds to altered hedonic processing during protracted morphine withdrawal. Behav Brain Res (2006) 1.10

Circuit projection from suprachiasmatic nucleus to ventral tegmental area: a novel circadian output pathway. Eur J Neurosci (2008) 1.08

No effect of morphine on ventral tegmental dopamine neurons during withdrawal. J Neurosci (2006) 1.08

Orexin/hypocretin modulates response of ventral tegmental dopamine neurons to prefrontal activation: diurnal influences. J Neurosci (2010) 1.07

Role of orexin/hypocretin in conditioned sucrose-seeking in rats. Psychopharmacology (Berl) (2012) 1.05

The behavioral economics of drug self-administration: a review and new analytical approach for within-session procedures. Psychopharmacology (Berl) (2012) 1.02

Halothane-induced hypnosis is not accompanied by inactivation of orexinergic output in rodents. Anesthesiology (2009) 1.00

A rodent "self-report" measure of methamphetamine craving? Rat ultrasonic vocalizations during methamphetamine self-administration, extinction, and reinstatement. Behav Brain Res (2012) 0.99

Orexin / hypocretin 1 receptor antagonist reduces heroin self-administration and cue-induced heroin seeking. Eur J Neurosci (2012) 0.99

Circadian regulation of arousal: role of the noradrenergic locus coeruleus system and light exposure. Sleep (2006) 0.97

Role of orexin input in the diurnal rhythm of locus coeruleus impulse activity. Brain Res (2008) 0.97

Prolonged activation of mesolimbic dopaminergic neurons by morphine withdrawal following clonidine: participation of imidazoline and norepinephrine receptors. Neuropsychopharmacology (2003) 0.94

The emerging role of norepinephrine in cognitive dysfunctions of Parkinson's disease. Front Behav Neurosci (2012) 0.93

Use of vivo-morpholinos for control of protein expression in the adult rat brain. J Neurosci Methods (2011) 0.91

Regulation of the ventral tegmental area by the bed nucleus of the stria terminalis is required for expression of cocaine preference. Eur J Neurosci (2012) 0.91

Cognitive neuroscience: decision amid uncertainty. Nature (2005) 0.91

Modafinil attenuates reinstatement of cocaine seeking: role for cystine-glutamate exchange and metabotropic glutamate receptors. Addict Biol (2012) 0.89

Modafinil blocks reinstatement of extinguished opiate-seeking in rats: mediation by a glutamate mechanism. Neuropsychopharmacology (2010) 0.88

Simplified dynamics in a model of noradrenergic modulation of cognitive performance. Neural Netw (2002) 0.86

Lateral hypothalamic orexin/hypocretin neurons that project to ventral tegmental area are differentially activated with morphine preference. J Neurosci (2012) 0.86

3-Monoiodothyronamine: the rationale for its action as an endogenous adrenergic-blocking neuromodulator. Brain Res (2010) 0.85

A noradrenergic lesion exacerbates neurodegeneration in a Down syndrome mouse model. J Alzheimers Dis (2011) 0.83

Orexin-1 receptor signaling increases motivation for cocaine-associated cues. Eur J Neurosci (2015) 0.83

Attenuation of saccharin-seeking in rats by orexin/hypocretin receptor 1 antagonist. Psychopharmacology (Berl) (2013) 0.82

New tricks for old dogmas: optogenetic and designer receptor insights for Parkinson's disease. Brain Res (2013) 0.81

Bayesian nonparametric analysis of neuronal intensity rates. J Neurosci Methods (2011) 0.80

Orbitofrontal and insular cortex: neural responses to cocaine-associated cues and cocaine self-administration. Synapse (2010) 0.80

The influence of spike rate and stimulus duration on noradrenergic neurons. J Comput Neurosci (2004) 0.79

Modafinil: an anti-relapse medication. Neuropsychopharmacology (2010) 0.78

Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats. Neuropharmacology (2012) 0.78

The highly selective orexin/hypocretin 1 receptor antagonist GSK1059865 potently reduces ethanol drinking in ethanol dependent mice. Brain Res (2016) 0.78

Session-long modulations of accumbal firing during sucrose-reinforced operant behavior. Synapse (2006) 0.77

Special issue on neuropeptides in stress and addiction: Overview. Brain Res (2010) 0.77

Assessment of a proposed "three-criteria" cocaine addiction model for use in reinstatement studies with rats. Psychopharmacology (Berl) (2014) 0.76

Inactivating the activated: identifying functions of specific neural networks. Nat Neurosci (2009) 0.75

Designer receptors: therapeutic adjuncts to cell replacement therapy in Parkinson's disease. J Clin Invest (2014) 0.75

Introduction to the special issue: "Role of corticostriatal circuits in addiction". Brain Res (2015) 0.75